Metagenomi
Discovering the next generation of gene-editing systems for use in treating genetic diseases. Learn more
Launch date
Employees
Market cap
€91.9m
Enterprise valuation
(€137m) (Public information from Sep 2024)
Share price
$2.66 MGX
Emeryville California (HQ)
Authorizing premium user...